InsiderClue
Insiders · Profile

Powchik Peter

SVP Clinical Development & Reg at Regeneron Pharmaceuticals. Filing since 26 Jul 2011. CIK 0001377247

Company
Date
Role
Action
Shares
Amount
Of holding
REGN Regeneron Pharmaceuticals
14 Aug 2015
SVP Clinical Development & Reg
Sold, plan not stated
23,485
$13.47M
59.7%
REGN Regeneron Pharmaceuticals
2 Jan 2015
SVP Clinical Development & Reg
Sold, plan not stated
10,822
$4.48M
50.3%
REGN Regeneron Pharmaceuticals
2 Jan 2014
SVP Clinical Development & Reg
Sold, plan not stated
20,668
$5.68M
44.8%
REGN Regeneron Pharmaceuticals
20 Dec 2013
SVP Clinical Development & Reg
Sold, plan not stated
133
$36.05K
0.6%
REGN Regeneron Pharmaceuticals
18 Dec 2013
SVP Clinical Development & Reg
Sold, plan not stated
9,000
$2.43M
30.3%
REGN Regeneron Pharmaceuticals
17 Dec 2013
SVP Clinical Development & Reg
Sold, plan not stated
8
$2.16K
0.0%
REGN Regeneron Pharmaceuticals
3 Jan 2013
SVP Clin Devel & Reg Affairs
Sold, plan not stated
13,586
$2.47M
47.5%
REGN Regeneron Pharmaceuticals
20 Dec 2012
SVP Clin Devel & Reg Affairs
Sold, plan not stated
6,623
$1.13M
30.6%
REGN Regeneron Pharmaceuticals
19 Dec 2012
SVP Clin Devel & Reg Affairs
Sold, plan not stated
10,356
$1.85M
32.4%
REGN Regeneron Pharmaceuticals
8 Nov 2012
SVP Clinical Development & Reg
Sold, plan not stated
15,144
$2.10M
50.3%
REGN Regeneron Pharmaceuticals
19 Sep 2012
SVP Clinical Development & Reg
Sold, plan not stated
7,177
$1.06M
19.2%
REGN Regeneron Pharmaceuticals
26 Jul 2012
SVP Clinical Development & Reg
Sold, plan not stated
7,019
$916.95K
31.7%
REGN Regeneron Pharmaceuticals
22 Feb 2012
SVP Clinical Development & Reg
Sold, plan not stated
49,254
$4.75M
76.5%
REGN Regeneron Pharmaceuticals
26 Jul 2011
SVP Clinical Development
Sold, plan not stated
10,977
$602.49K
100%
14 decisions on file.